EMCDDA Document Library

Displaying 1 - 10 of 73

no image available

Increasing potency and price of cannabis in Europe, 2006‐2016

This article examines the increasing potency and price of cannabis in Europe, covering the time period 2006-2016. It set out to quantify changes in (i) potency (concentration of Δ9‐tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value (mg THC/euro) of cannabis resin and...

2018 Annual report on public requests to access to the EMCDDA documents

Annual report on public requests to access to the EMCDDA documents.

no image available

The challenge of responding to a more globally joined-up, dynamic, and innovative drug market: Reflections from the EMCDDA's 2018 analysis of the European drug situation

Agenda and minutes of the 58th EMCDDA Management Board (13-14 December 2018)

Agenda and minutes of the 58th Management Board meeting that took place on 13-14 December 2018 at the EMCDDA

no image available

EMCDDA-Europol working arrangement, 2018

This is the updated EMCDDA–Europol working arrangement signed in Brussels on 6 December 2018 by EMCDDA Director Alexis Goosdeel and Europol Director Catherine de Bolle.

no image available

EMCDDA-EMA working arrangement, 2018

This is the updated EMCDDA–Europol working arrangement signed in London on 7 December 2018 by EMCDDA Director Alexis Goosdeel and EMA Director Guido Rasi.

no image available

EMCDDA-ECDC working arrangement, 2018

This is the updated EMCDDA–ECDC working arrangement signed in Brussels on 4 December 2018 by EMCDDA Director Alexis Goosdeel and ECDC Director Andrea Ammon.

no image available

The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic

no image available

Concurrent use of benzodiazepine by heroin users-what are the prevalence and the risks associated with this pattern of use?

no image available

Review of Northern Ireland's New Strategic Direction for Alcohol and Drugs - Phase 2

This report presents the Institute of Public Health in Ireland's Review of Northern Ireland's New Strategic Direction for Alcohol and Drugs - Phase 2.

1
2
3
4
5
6
7
8
next ›

.